Similar articles for PMID: 18192521

Year	Number of Results
2004	1
2007	2
2008	13
2009	10
2016	1
2024	0

1

An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in overweight and obese people with type 2 diabetes.

Chyun D. Chyun D. Evid Based Nurs. 2008 Jan;11(1):16. doi: 10.1136/ebn.11.1.16. Evid Based Nurs. 2008. PMID: 18192521 No abstract available.

2

Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.

Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study (DPS) Group. Lindström J, et al. Diabetes Care. 2008 May;31(5):857-62. doi: 10.2337/dc07-2162. Epub 2008 Feb 5. Diabetes Care. 2008. PMID: 18252900

3

An intensive lifestyle intervention reduced weight and cardiovascular disease risk factors in obese participants with type 2 diabetes at 1 year in an interim analysis.

Padwal R. Padwal R. Evid Based Med. 2007 Dec;12(6):180. doi: 10.1136/ebm.12.6.180. Evid Based Med. 2007. PMID: 18063740 No abstract available.

4

Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.

Caballero AE. Caballero AE. J Diabetes Complications. 2009 Mar-Apr;23(2):143-52. doi: 10.1016/j.jdiacomp.2007.06.002. Epub 2008 Apr 16. J Diabetes Complications. 2009. PMID: 18413192 Review.

5

Sustainability of lifestyle changes following an intensive lifestyle intervention in insulin resistant adults: Follow-up at 2-years.

Dale KS, Mann JI, McAuley KA, Williams SM, Farmer VL. Dale KS, et al. Asia Pac J Clin Nutr. 2009;18(1):114-20. Asia Pac J Clin Nutr. 2009. PMID: 19329404 Free article. Clinical Trial.

6

Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

Andersson C, Weeke P, Fosbøl EL, Brendorp B, Køber L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, Torp-Pedersen C; SCOUT Executive Steering Committee; SCOUT investigators. Andersson C, et al. Metabolism. 2009 Aug;58(8):1109-15. doi: 10.1016/j.metabol.2009.04.003. Epub 2009 Jun 18. Metabolism. 2009. PMID: 19454355 Clinical Trial.

7

Survey of cardiovascular risk factors in overweight and obese patients (SCOOP study) six-month changes in risk factor levels and cardiovascular risk.

Iori I, Fatati G, Fusco MA, Leonardi F, Matthieu G, Scanelli G, Lanti M, Menotti A. Iori I, et al. Eur J Intern Med. 2009 May;20(3):280-8. doi: 10.1016/j.ejim.2008.10.001. Epub 2008 Nov 12. Eur J Intern Med. 2009. PMID: 19393495

8

The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.

Andreadis EA, Katsanou PM, Georgiopoulos DX, Tsourous GI, Yfanti GK, Gouveri ET, Diamantopoulos EJ. Andreadis EA, et al. Exp Clin Endocrinol Diabetes. 2009 Apr;117(4):175-80. doi: 10.1055/s-0028-1087177. Epub 2008 Dec 3. Exp Clin Endocrinol Diabetes. 2009. PMID: 19053032

9

A review and meta-analysis of the effect of weight loss on all-cause mortality risk.

Harrington M, Gibson S, Cottrell RC. Harrington M, et al. Nutr Res Rev. 2009 Jun;22(1):93-108. doi: 10.1017/S0954422409990035. Nutr Res Rev. 2009. PMID: 19555520 Review.

10

Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.

Bossola M, Giungi S, Panocchia N, Vulpio C, Luciani G, Tazza L. Bossola M, et al. J Nephrol. 2008 Mar-Apr;21(2):197-204. J Nephrol. 2008. PMID: 18446714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year